POA
GILD icon

Pergamon Offshore Advisors’s Gilead Sciences GILD Stock Holding History

Pergamon Offshore Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,753
Closed -$1.3M – 195
2014
Q4 		$1.3M Buy
+13,753
New +$1.42M 1.21% 9

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Pergamon Offshore Advisors's GILD Position: Q1 2015 in Review

Pergamon Offshore Advisors sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 13,753 shares — an estimated $1.3M sold.

Pergamon Offshore Advisors first reported a position in GILD in Q4 2014 and held it in 1 quarter. The position peaked at $1.3M in Q4 2014. 1,493 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Pergamon Offshore Advisors reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Pergamon Offshore Advisors sold 13,753 Gilead Sciences shares in Q1 2015, an estimated $1.3M.
  • Pergamon Offshore Advisors first reported a position in Gilead Sciences in Q4 2014 and held it in 1 quarter.
  • Pergamon Offshore Advisors's Gilead Sciences position peaked at $1.3M in Q4 2014.
  • 1,493 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Pergamon Offshore Advisors's 13F filing for Q1 2015, filed 6 May 2015.